Mass spectrometry & spectroscopy
Expect More Productivity Evolving with the changing laboratory environment
Oct 31 2014
The pressure on analytical laboratories has never been greater. Managers face a dynamic environment of changing regulatory requirements, lower detection levels, more compounds, less time, lower budgets, and increased competition. Laboratories must evolve to stay ahead of the game, and their analytical systems need to evolve, too.
The Thermo Scientific™ TSQ™ 8000 Evo Triple Quadrupole GC-MS/MS is for labs looking for the next step up in triple quadrupole GC-MS/MS productivity. It is the latest evolution of the highly successful TSQ 8000 GC-MS/MS system and the evolution of unstoppable productivity, MS/MS simplicity, and ultimate performance SRM.
The TSQ 8000 Evo triple quadrupole GC-MS/MS has been designed for and developed with high throughput analytical laboratories. It is a unique system that offers a harmonious combination of hardware and software features that help laboratories adapt to their changing environment and deliver quality results on time, every time.
Fast EvoCell technology and intelligent instrument control
The TSQ 8000 Evo triple quadrupole GC-MS/MS offers more capacity through acquisition of more information, more compounds, and more results per unit time in your laboratory. This enables higher levels of productivity and efficiency in analytical workflows. Innovative EvoCell collision cell technology, in combination with the high efficiency timed-SRM capability of the system, opens the door to new possibilities for high-complexity methods in routine laboratories.
Digital Edition
Lab Asia 32.1 Feb 2025
February 2025
Chromatography Articles - Comparing volumetric and thermal flowmeters for assessing and validating liquid chromatography performance Mass Spectrometry & Spectroscopy Articles - The importa...
View all digital editions
Events
SPS Smart Production Solutions Guangzhou
Feb 25 2025 Guanghzou, China
Feb 25 2025 Amsterdam, Netherlands
Feb 27 2025 Kathmandu, Nepal
Mar 01 2025 Boston, MA, USA
Mar 02 2025 Bethesda, MD, USA